Fundraising Fox

EVQLV

Techstars '20

Woodside, US · Founded 2019 · 4 employees on LinkedIn · 8 known investors

EVQLV develops a computational platform for antibody discovery that uses machine learning and computational biology to accelerate and reduce the cost of generating fully-human antibodies for drug development. The platform serves pharmaceutical and biotech partners working on antibody therapeutics.

AI & Machine LearningBiotechDeep TechHealthtech

Investors · 8

Bantam GroupWestwood
Beresford VenturesOrlando
Tamiami AngelNaples
TBD AngelsNew York
TechstarsBoulder · $220K
BIP VenturesreportedAtlanta
Florida FundersreportedTampa · $50K
MEDINA VENTURESreportedMiami

In the news

AI, meet antibodies. Inside EVQLV’s 'ChatGPT moment for biology' - Refresh Miamirefreshmiami.com · Nov 2025eMerge win will fuel EVQLV’s growth toward building a future of personalized medicine - Refresh Miamirefreshmiami.com · Apr 2024Hatter Angel Network Invests to Accelerate Growth in Biotechnology - Stetson Todaywww2.stetson.edu · Mar 2023Stetson students partner with biotech company to obtain $135,000 in funding | Observer Local News | Palm Coast Observer and Ormond Beach Observerobserverlocalnews.com · Mar 2023Life sciences startup EVQLV is leveraging AI to sell antibody sequences - Refresh Miamirefreshmiami.com · Mar 2023

Frequently asked questions

What does EVQLV do?
EVQLV develops a computational platform for antibody discovery that uses machine learning and computational biology to accelerate and reduce the cost of generating fully-human antibodies for drug development. The platform serves pharmaceutical and biotech partners working on antibody therapeutics.
Who are EVQLV's investors?
EVQLV's investors include Bantam Group, Beresford Ventures, Tamiami Angel, TBD Angels, Techstars, BIP Ventures, Florida Funders, MEDINA VENTURES.
Where is EVQLV headquartered?
EVQLV is headquartered in Woodside, US.